...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ANYTHING ON THE SHOWCASE?

BDAZ - In a round about way yesterday I heard that Clayton said the slide decks that were used in yesterday's presentations would be posted to the respective sites over the next few days. They will be basically the same as what was presented at the AGM's with just a couple of slides changed.

tada

Share
New Message
Please login to post a reply